Link to the feature: www.criver.com/insights/ai-...

AI-enabled RNA design for ultra-rare diseases was on stage at PMWC and in a new Charles River feature last week. Two signs of a growing conversation around what is now possible. Link in comments.

#RNA #PrecisionMedicine #RareDisease

Therna Announces Collaboration with Charles River to Advance Single-Patient Personalized RNA Therapeutics /PRNewswire/ -- Therna Biosciences, a biotechnology company pioneering programmable RNA therapeutics, today announced a collaboration with Charles River to...

Read the full announcement here: www.prnewswire.com/news-release...

Two urgent patients. One AI-driven approach. At PMWC, we are unveiling our collaboration with Charles River Labs to advance single-patient RNA medicines for ultra-rare conditions. Our AI platform designed better candidates, faster. #PrecisionMedicine #RareDisease #RNA

Therna Biosciences Appoints Biotech Veteran Devyn Smith, Ph.D., to Board of Directors and Expands Strategic and Scientific Advisory Leadership:

Read the full news here: www.prnewswire.com/news-release...

Therna Biosciences has joined the NVIDIA Inception program, building on our work with NVIDIA and CodonFM to advance AI-driven RNA design and programmable RNA therapeutics.

#NVIDIAInception #AI #RNA

The Case for Foundation Models in Biology Rethinking scale: context, diversity, and design for biological foundation models

Foundation models are essential for biology. Scaling is not failing but requires the right customization. They are indispensable in data-sparse domains and will drive the next decade of discovery. blog.therna.com/p/the-case-f...

Therna Biosciences Launches with Proprietary Generative AI Models for Designing Programmable RNA Medicines Therna Biosciences today announced its launch with a vision to transform the development of RNA medicines through a biology-guided, AI-powered platform. By decoding the language of RNA, Therna is pio...

Excited to announce the launch of Therna Biosciences, The RNA company. By combining RNA biology with generative AI, we’re building programmable RNA medicines with greater durability, specificity and efficacy. Backed by $10M seed funding.
www.webwire.com/ViewPressRel...